You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tipiracil Hydrochloride And Trifluridine, and what generic alternatives are available?

Tipiracil Hydrochloride And Trifluridine is a drug marketed by Natco and is included in one NDA.

The generic ingredient in TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE is tipiracil hydrochloride; trifluridine. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the tipiracil hydrochloride; trifluridine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Tipiracil Hydrochloride And Trifluridine

A generic version of TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE was approved as tipiracil hydrochloride; trifluridine by NATCO on June 13th, 2023.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE?
  • What are the global sales for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE?
  • What is Average Wholesale Price for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE?
Summary for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 57
DailyMed Link:TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE at DailyMed
Drug patent expirations by year for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
Recent Clinical Trials for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
Sun Yat-sen UniversityPhase 2
Yonsei UniversityPhase 1/Phase 2

See all TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE clinical trials

US Patents and Regulatory Information for TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Natco TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE tipiracil hydrochloride; trifluridine TABLET;ORAL 214008-001 Jun 13, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Natco TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE tipiracil hydrochloride; trifluridine TABLET;ORAL 214008-002 Jun 13, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.